Avalon Pharma Announces Strategic Partnership with Glatt for Future Manufacturing Facility Design

engineering and process technology, to develop the detailed conceptual design of our upcoming state-of-the-art manufacturing facilities.

This collaboration is a major step in alignment with Saudi Arabia’s Vision 2030 and the national goal to localize the production of advanced pharmaceuticals.

Through this partnership, Avalon Pharma aims to expand its product portfolio to include Oncology, Parenteral, and Ophthalmic therapies, leveraging cutting-edge design and engineering to deliver high-quality, specialized treatments to patients.

We believe this collaboration marks a transformative milestone in Avalon Pharma’s journey to becoming a leader in the pharmaceutical manufacturing landscape, both regionally and globally. Together, we move forward with innovation and purpose to deliver sustainable health solutions for the future.